nasdaq:hrtx
|
3767623
|
May 5th, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
180.00
|
Open
|
|
May 4th, 2024 11:38PM
|
May 4th, 2024 11:38PM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
May 4th, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
180.00
|
Open
|
|
May 3rd, 2024 11:12PM
|
May 4th, 2024 06:51PM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
May 3rd, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
180.00
|
Open
|
|
May 2nd, 2024 11:07PM
|
May 3rd, 2024 02:37PM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
May 2nd, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
180.00
|
Open
|
|
May 1st, 2024 11:16PM
|
May 2nd, 2024 10:14AM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
May 1st, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
179.00
|
Open
|
|
May 1st, 2024 12:16AM
|
May 1st, 2024 09:39AM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
Apr 30th, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
179.00
|
Open
|
|
Apr 29th, 2024 11:35PM
|
Apr 30th, 2024 08:32AM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
Apr 29th, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
179.00
|
Open
|
|
Apr 28th, 2024 11:58PM
|
Apr 29th, 2024 09:40AM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
Apr 28th, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
179.00
|
Open
|
|
Apr 27th, 2024 11:29PM
|
Apr 27th, 2024 11:29PM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
Apr 27th, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
179.00
|
Open
|
|
Apr 26th, 2024 11:08PM
|
Apr 26th, 2024 11:08PM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|
nasdaq:hrtx
|
3767623
|
Apr 26th, 2024 12:00AM
|
Heron Therapeutics, Inc.
|
13K
|
179.00
|
Open
|
|
Apr 25th, 2024 11:16PM
|
Apr 26th, 2024 08:36AM
|
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
|
Open
|
Chemotherapy Induced Nasea and Vomiting (CINV) and Post-Surgical Pain
|
Open
|
4242 Campus Point Court
|
San Diego
|
CA
|
US
|
92121
|
|
Heron Therapeutics
|
|
Pharmaceuticals & Biotechnology
|